Foghorn Therapeutics Inc. SEC filings FHTX
Foghorn Therapeutics Inc. has 354 filings in SEC EDGAR's recent list, going back to Aug 28, 2020. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (exit or restructuring costs, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 26, 2026 | — |
| 424B5 | Prospectus supplement | Jan 12, 2026 | — |
| 424B5 | Prospectus supplement | Mar 20, 2025 | — |
| S-3 | Shelf registration | Jan 24, 2025 | — |
| S-8 | Employee stock plan registration | Jan 24, 2025 | — |
| 424B5 | Prospectus supplement | Aug 8, 2024 | — |
| 424B5 | Prospectus supplement | May 20, 2024 | — |
| S-8 | Employee stock plan registration | May 6, 2024 | — |
| S-8 | Employee stock plan registration | May 8, 2023 | — |
| 424B5 | Prospectus supplement | Apr 15, 2022 | — |
| POS AM | Filing | Apr 15, 2022 | — |
| S-8 | Employee stock plan registration | Feb 14, 2022 | — |
| S-3 | Shelf registration | Feb 14, 2022 | — |
| S-8 | Employee stock plan registration | Jan 15, 2021 | — |
| 424B4 | Prospectus | Oct 26, 2020 | — |
| 424B4 | Prospectus | Oct 23, 2020 | — |
| S-1/A | Amended registration statement | Oct 22, 2020 | — |
| S-1/A | Amended registration statement | Oct 19, 2020 | — |
| S-1 | Registration statement | Oct 2, 2020 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FHTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1822462
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.